Search for: "AMGEN INC."
Results 641 - 660
of 707
Sort by Relevance
|
Sort by Date
17 Apr 2008, 10:39 am
Feb. 29, 2008) ("The court may take judicial notice of the FDA letters submitted by the parties"); In re Amgen Inc. [read post]
11 Apr 2008, 9:00 am
Forest Laboratories, Inc. turns law of declaratory judgment on its head: (Patent Docs), (Patent Baristas), Mircera (Methoxy polyethylene glycol-epoetin beta) – Roche appeals preliminary injunction barring US sales of Mircera in patent infringement battle with Amgen: (Philip Brooks), (IP Law360), Norvasc (Amlodipine) – Ranbaxy becomes first foreign generic company to develop a generic product independently outside Japan and receive authorization from… [read post]
4 Apr 2008, 1:00 am
: (IPBiz) Pharma & Biotech - Products Abilify (Aripiprazole) – Otsuka files US patent infringement suit against Teva over seeking approval for generic Abilify: (IP Law360), Aricept (Donepezil) – US federal judge grants Eisai’s request for preliminary injunction blocking Teva from marketing generic version of Aricept: (IP Law360), (Orange Book Blog), Carbatrol (Carbamazepine) – US federal judge delivers mixed ruling in Shire… [read post]
1 Apr 2008, 2:16 am
Teva Pharmaceuticals USA, Inc. [read post]
28 Mar 2008, 6:00 am
: (Afro-IP),If education and pricing policy fail, says Adobe in Nigeria, we can still sue: (Afro-IP),South African arm of Chrysler objects to advertisement by Indian vehicle maker Mahindra and Mahindra that uses the term "jeep": (Afro-IP), (Spicy IP),Kenya’s call for anti-counterfeit legislation… amongst other changes: (Afro-IP),Kenya: Shared computer use raises privacy, confidentiality issues: (Afro-IP)AustraliaChanges to grace period for trade mark renewal:… [read post]
26 Mar 2008, 9:11 pm
Noonan -- Obtaining an injunction against an adjudged infringer has become much more difficult for patentees since the Supreme Court's decision in eBay Inc. v. [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in India and… [read post]
20 Mar 2008, 10:01 pm
Switzerland based Biotechnology Company; Roche Holding AG who developed pegylated version of Erythropoietin (MIRCERA ®) said on Tuesday that they agreed to conditions set by the federal judge of the United States district court of Massachusetts, overseeing a patent case brought by Amgen Inc, which could clear the way for Roche to sell its anemia drug MIRCERA ® in the United States. [read post]
20 Mar 2008, 9:56 pm
Federal Circuit Gives Amgen a Mixed Decision on Its ITC Complaint against Roche's Mircera ® By Kevin E. [read post]
20 Mar 2008, 8:18 am
In Amgen Inc. v. [read post]
19 Mar 2008, 3:17 pm
The ITC's jurisdiction under § 1337, according to the court, is broad, and it therefore erred in holding that it lacked jurisdiction absent an actual sale or contract for sale of the imported product.More detail of Amgen, Inc. v. [read post]
12 Mar 2008, 8:49 am
Today's Wall Street Journal has another piece on potential further restrictions on anemia drugs sold by Amgen, Inc. and Johnson & Johnson (see Byron's post for the earlier article). [read post]
9 Mar 2008, 6:43 pm
Here's an excerpt: Drug maker Amgen Inc. says regulators have added new warnings about risks of death and... [read post]
7 Mar 2008, 2:00 am
: (IP ThinkTank) Global - Copyright Copyright ‘evergreening’: (IP ThinkTank), The international copyright system: limitations, exceptions and public interest considerations for developing countries and the digital environment: (IP Justice), When copyright forces copying against your will: (Against Monopoly), (Techdirt), Encyclopedia of Life launches, publishes articles under CC licences: (creativecommons.org), Nine Inch Nails adopt successful experimental… [read post]
22 Feb 2008, 6:00 pm
Signature Financial Group, Inc., and AT&T Corp. v. [read post]
22 Feb 2008, 1:30 pm
Medtronic Inc., No. 06-179, Justice Antonin Scalia said that permitting state juries to impose liability on the maker of an approved device “disrupts the federal scheme,” under which the F.D.A. has the responsibility for evaluating the risks and benefits of a new device and assuring that it is safe and effective for its intended use. [read post]
11 Feb 2008, 8:08 am
Amgen, Inc., No. 07-1999 "In an action against defendant charging fraudulent pricing of pharmaceutical drugs in violation of Wisconsin state law, an order remanding the case and sanctioning defendant is affirmed in part as to the remand order, but reversed as to the sanctions where: 1) the filing of a suit under the False Claims Act did not render this case removable; and 2) the paucity of appellate authority on the removability issue gave defendant a reasonable basis for… [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]
7 Feb 2008, 8:48 pm
Del.) granted leave to Amgen Inc. to amend and supplement its reply to ARIAD Pharmaceuticals Inc.'s counterclaims to include new claims of inequitable conduct. [read post]
5 Feb 2008, 11:03 am
Heintz of Porter Wright Morris & Arthur in the firm's Nanotechnology Law Report Podcast of Maniloff's top ten insurance coverage cases of 2007 - Portland attorney David Rossmiller of Dunn Carney in the firm's Insurance Coverage Law Blog Implications of the Amgen-Takeda deal - Management consultant Cliff Mintz of BioInsights Inc. in his Bio Job Blog [read post]
